U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 131

Tests names and labsConditionsGenes, analytes, and microbesMethods

CFI Gene Hemolytic uremic syndrome NGS Genetic DNA Test

DNA Labs India
India
11
  • S Mutation scanning of the entire coding region

Comprehensive Nephrology Gene Panel

Mayo Clinic Laboratories Mayo Clinic
United States
1299
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Atypical Hemolytic Uremic Syndrome (aHUS)/Thrombotic Microangiopathy (TMA) /Complement 3 Glomerulopathy (C3G) Gene Panel, Varies

Mayo Clinic Laboratories Mayo Clinic
United States
515
  • C Sequence analysis of the entire coding region

Genetic Renal Panel v8

Molecular Otolaryngology and Renal Research Laboratories University of Iowa Hospital and Clinics
United States
2117
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

TMA-Complete Genetic Panel 3.0

Machaon Diagnostics
United States
624
  • E Sequence analysis of select exons

Invitae Expanded Renal Disease Panel

Invitae
United States
693388
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

GenepoweRx_Nephro_Care

GenepoweRx Uppaluri K&H Personalized Medicine Clinic
India
2758
  • D Deletion/duplication analysis
  • H Detection of homozygosity
  • S Mutation scanning of the entire coding region
  • T Targeted variant analysis

CFI - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoImmuno Panel

Centogene AG - the Rare Disease Company
Germany
323329
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Atypical Hemolytic Uremic Syndrome (aHUS) Panel

Centogene AG - the Rare Disease Company
Germany
2325
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Macular Dystrophy Panel

Invitae
United States
6636
  • D Deletion/duplication analysis

Invitae Inborn Errors of Immunity and Cytopenias Panel

Invitae
United States
755562
  • D Deletion/duplication analysis

Invitae Complement Deficiency Disorders Panel

Invitae
United States
3522
  • D Deletion/duplication analysis

Invitae Atypical Hemolytic Uremic Syndrome and Thrombotic Microangiopathies Panel

Invitae
United States
2513
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

C3 Glomerularopathy Genetic Panel (6 genes) (2 Day STAT TAT)

Machaon Diagnostics
United States
36
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Atypical hemolytic uremic syndrome susceptibility and related disorders Deletion/ Duplication panel

HNL Genomics Connective Tissue Gene Tests
United States
113
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Atypical hemolytic uremic syndrome susceptibility and related disorders Comprehensive panel

HNL Genomics Connective Tissue Gene Tests
United States
113
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Atypical hemolytic uremic syndrome susceptibility and related disorders NGS panel

HNL Genomics Connective Tissue Gene Tests
United States
113
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Complement factor I deficiency, 610984, Autosomal recessive; CFID (Immunodeficiency with factor I anomaly) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Complement factor I deficiency, 610984, Autosomal recessive; CFID (Immunodeficiency with factor I anomaly) (Prenatal) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Results: 1 to 20 of 131

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.